Assignee
E THERAPEUTICS PLC
GB·7 granted patents·18 pending applications·4 citations·filing 2008–2025
Top patents by PatentIndex Score
25 records- 0180US7768942B2Identifying components of a network having high importance for network integrityE THERAPEUTICS PLC·Filed 2008·Granted Aug 3, 2010·2 cites·18 claims
- 0278US7990878B2Identifying components of a network having high importance for network integrityE THERAPEUTICS PLC·Filed 2009·Granted Aug 2, 2011·1 cites·22 claims
- 0372US12435337B2Inhibitors of expression and/or functionE THERAPEUTICS PLC·Filed 2024·Granted Oct 7, 2025·0 cites·19 claims
- 0465US12338438B2Conjugated oligonucleotide compounds, methods of making and uses thereofE THERAPEUTICS PLC·Filed 2023·Granted Jun 24, 2025·0 cites·19 claims
- 0564US9002658B2Identifying components of a network having high importance for network integrityE THERAPEUTICS PLC·Filed 2012·Granted Apr 7, 2015·1 cites·25 claims
- 0661US2026085314A1Conjugated oligonucleotide compounds, methods of making and uses thereofE THERAPEUTICS PLC·Filed 2025·Application pending·0 cites
- 0760US2025304969A1Inhibitors of expression and/or functionE THERAPEUTICS PLC·Filed 2025·Application pending·0 cites
- 0858US2024352458A1Double stranded nucleic acid compounds inhibiting zpiE THERAPEUTICS PLC·Filed 2024·Application pending·0 cites
- 0957US2025368992A1Nucleic acid compoundsE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1057US2025376680A1Nucleic acid compoundsE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1156US2025388897A1Nucleic acid compoundsE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1256US2023407311A1Nucleic acids containing abasic nucleotidesE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1355US10450251B2Process for the preparation of 3-substituted cannabinoid compoundsE THERAPEUTICS PLC·Filed 2016·Granted Oct 22, 2019·0 cites·16 claims
- 1455US2025320494A1Inhibitors of expression and/or functionE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1553US2023310486A1Conjugated oligonucleotide compounds, methods of making and uses thereofE THERAPEUTICS PLC·Filed 2023·Application pending·0 cites
- 1653US2025002913A1Nucleic acids containing abasic nucleosidesE THERAPEUTICS PLC·Filed 2022·Application pending·0 cites
- 1746US2015093438A1Tramadol for Treating DepressionE THERAPEUTICS PLC·Filed 2013·Application pending·0 cites
- 1845US2013296437A1Treatment of DepressionE THERAPEUTICS PLC·Filed 2013·Application pending·0 cites
- 1944US2018042891A1Cancer Cell ApoptosisE THERAPEUTICS PLC·Filed 2017·Application pending·0 cites
- 2041US2026009036A1Inhibitors of expression and/or functionE THERAPEUTICS PLC·Filed 2025·Application pending·0 cites
- 2139US2011020217A1Treatment of melanomaE THERAPEUTICS PLC·Filed 2008·Application pending·0 cites
- 2238US2011039906A1Antibacterial combination therapyE THERAPEUTICS PLC·Filed 2008·Application pending·0 cites
- 2338US2015072020A1Dexanabinol or a Derivative Thereof for Use in the Treatment of Cancer in Dose Ranges of 2-30 mg/kgE THERAPEUTICS PLC·Filed 2013·Application pending·0 cites
- 2425US2021238139A1Modulators of tryptophan catabolismE THERAPEUTICS PLC·Filed 2019·Application pending·0 cites
- 2521US10961238B2Modulators of hedgehog (Hh) signaling pathwayE THERAPEUTICS PLC·Filed 2017·Granted Mar 30, 2021·0 cites·18 claims
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →